Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_assertion description "[TET2 loss-of-function mutations are highly frequent in subtypes of T-cell lymphoma that harbor follicular helper T (Tfh)-cell-like features, such as angioimmunoblastic T-cell lymphoma (30-83%) or peripheral T-cell lymphoma, not otherwise specified (10-49%), as well as myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_assertion evidence source_evidence_literature NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_assertion SIO_000772 25501021 NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_assertion wasDerivedFrom befree-2016 NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_assertion wasGeneratedBy ECO_0000203 NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247437.RAljOP-OlHr5ULsWEuQFSlYCJ0ExDJIKbN4H5r2sErjeo130_provenance.